155 related articles for article (PubMed ID: 35961103)
21. Amelioration of intracellular Ca
Sato M; Shiba N; Miyazaki D; Shiba Y; Echigoya Y; Yokota T; Takizawa H; Aoki Y; Takeda S; Nakamura A
Biochem Biophys Res Commun; 2019 Nov; 520(1):179-185. PubMed ID: 31585729
[TBL] [Abstract][Full Text] [Related]
22. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
23. Generation of ZZUi008-A, a transgene-free, induced pluripotent stem cell line derived from chorionic villi cells of a fetus with Duchenne muscular dystrophy.
Zhu X; Cai A; Meng J; Liu L; Cui S; Qu S; Zhao J; Liu N; Kong X
Stem Cell Res; 2018 Oct; 32():47-50. PubMed ID: 30172907
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
[TBL] [Abstract][Full Text] [Related]
25. IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.
Soussi S; Savchenko L; Rovina D; Iacovoni JS; Gottinger A; Vialettes M; Pioner JM; Farini A; Mallia S; Rabino M; Pompilio G; Parini A; Lairez O; Gowran A; Pizzinat N
Biol Direct; 2023 Jul; 18(1):41. PubMed ID: 37501163
[TBL] [Abstract][Full Text] [Related]
26. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
[TBL] [Abstract][Full Text] [Related]
27. Establishment of human induced pluripotent stem cell line MUi028-A from normal fetal skin fibroblasts.
Chumchuen S; Satirapod C; Tangprasittipap A; Hongeng S
Stem Cell Res; 2022 Apr; 60():102675. PubMed ID: 35114587
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O
Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499
[TBL] [Abstract][Full Text] [Related]
30. Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes.
Xiao R; Zhou M; Wang P; Zeng B; Wu L; Hu Z; Liang D
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012442
[TBL] [Abstract][Full Text] [Related]
31. Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing.
Chemello F; Chai AC; Li H; Rodriguez-Caycedo C; Sanchez-Ortiz E; Atmanli A; Mireault AA; Liu N; Bassel-Duby R; Olson EN
Sci Adv; 2021 Apr; 7(18):. PubMed ID: 33931459
[TBL] [Abstract][Full Text] [Related]
32. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
33. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
34. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
Lee Y; Jeong D; Ham S; Son J; Ko K
Stem Cell Res; 2024 Jun; 77():103416. PubMed ID: 38615589
[TBL] [Abstract][Full Text] [Related]
35. Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent.
Su J; Wang J; Wang L; Li T; Wang H; Shen J; Wang H; Zhang J; Lin W; Huang J; Liang P
Stem Cell Res; 2020 Dec; 49():102021. PubMed ID: 33039804
[TBL] [Abstract][Full Text] [Related]
36. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling.
Caputo L; Granados A; Lenzi J; Rosa A; Ait-Si-Ali S; Puri PL; Albini S
Skelet Muscle; 2020 May; 10(1):13. PubMed ID: 32359374
[TBL] [Abstract][Full Text] [Related]
37. Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells.
Zhao C; Farruggio AP; Bjornson CR; Chavez CL; Geisinger JM; Neal TL; Karow M; Calos MP
PLoS One; 2014; 9(4):e96279. PubMed ID: 24781921
[TBL] [Abstract][Full Text] [Related]
38. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
39. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
40. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
